Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

New compounds were made that effectively block a specific enzyme related to androgen conditions.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

Plant sterols have health benefits like lowering cholesterol, but more research is needed to understand their effects and improve their extraction and sustainability.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Certain drugs that block specific enzymes can help treat prostate diseases.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

New compounds were made that block an enzyme linked to breast cancer better than existing treatments.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Researchers found new potential treatments for conditions related to the androgen receptor, like male hormonal contraception, by testing thousands of compounds.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Paris polyphylla saponins may effectively treat acne due to their antibacterial and anti-inflammatory properties.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.